This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

PDL BioPharma Inc (PDLI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 94.30M 131.21M 168.54M 211.57M
Receivables 313.00K 7.87M 600.00K 469.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 5.95M
Total Current Assets 107.70M 182.98M 233.51M 284.66M
Property, Plant & Equipment, Gross 9.19M 9.19M 9.14M 9.14M
Accumulated Depreciation & Depletion 9.15M 9.13M 9.12M 9.06M
Property, Plant & Equipment, Net 41.00K 59.00K 22.00K 80.00K
Intangibles 235.68M 0.00 0.00 0.00
Other Non-Current Assets 193.84M 92.37M 24.46M 9.30M
Total Non-Current Assets 436.26M 96.98M 35.96M 32.00M
Liabilities & Shareholder Equity
Total Assets 543.96M 279.97M 269.47M 316.67M
Accounts Payable 287.00K 1.07M 528.00K 2.54M
Short Term Debt 74.40M 0.00 0.00 0.00
Other Current Liabilities 59.00K 287.00K 0.00 0.00
Total Current Liabilities 407.42M 10.47M 133.01M 193.99M
Long Term Debt 0.00 309.95M 316.62M 395.45M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 23.04M 27.66M 24.12M 51.41M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 23.04M 337.61M 340.74M 446.86M
Total Liabilities 430.47M 348.09M 473.74M 640.85M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 113.49M -68.12M -204.27M -324.18M
Common Par 1.40M 1.40M 1.40M 1.40M
Additional Paid In Capital -233.17M -234.07M -161.75M -87.37M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings 350.15M 169.63M -42.04M -241.42M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -4.89M -5.09M -1.88M 3.22M
Total Capitalization 113.49M 241.83M 112.34M 71.27M
Total Equity 113.49M -68.12M -204.27M -324.18M
Total Liabilities & Stock Equity 543.96M 279.97M 269.47M 316.67M
Total Common Shares Outstanding 139.94M 139.82M 139.68M 139.64M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 139.84M 139.71M 139.66M 126.58M
Diluted Weighted Shares Outstanding 159.34M 146.40M 177.44M 178.80M
Number of Employees 10 10 10 8
Number of Part-Time Employees 0 0 0 1

PDLI PDL BioPharma Inc

Analysts Ratings for PDLI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 1 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

PDLI Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs